Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results

Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.

from Health and Science https://ift.tt/uZnq4GJ
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L